Afya (AFYA) Q3 2024: Medical Student Base Climbs 12%, Margin Expansion Signals Operational Leverage
Afya’s Q3 marked a structural margin inflection, propelled by disciplined M&A and operational streamlining. The company’s medical student base and B2B medical practice contracts both posted double-digit growth, while integration of recent acquisitions and cost structure rationalization drove further margin expansion. Investor focus now shifts to continued margin leverage, M&A pipeline quality, and the sustainability of tuition and enrollment trends into 2025.
Summary
- Margin Expansion Outpaces Revenue: Operating leverage from integration and restructuring boosted profitability beyond top-line growth.
- Medical Ecosystem Deepens: Student and physician user bases grew, supporting B2B and digital monetization.
- M&A Pipeline Broadens: Lower acquisition multiples and disciplined capital allocation underpin future inorganic growth.
Business Overview
Afya is a leading Brazilian medical education and digital health platform, generating revenue through undergraduate and continuing education programs, as well as digital medical practice solutions. Its business is structured across three major segments: Undergraduate Medicine (core revenue driver, tuition-based), Continuing Education (postgraduate, residency, and B2B health training), and Medical Practice Solutions (digital tools and services for physicians and healthcare providers, monetized via subscriptions and B2B contracts). The company’s scale and integration across the medical education journey form a defensible ecosystem that supports recurring revenue and cross-segment synergies.
Performance Analysis
Afya delivered robust double-digit revenue and EBITDA growth, with net revenue up 16% year-over-year and adjusted EBITDA up 25%, reflecting a margin expansion of 290 basis points. The company’s ability to expand gross margin in its undergraduate segment, driven by tuition increases and maturation of medical seats, was complemented by operational efficiencies realized from the integration of recent acquisitions (notably Unidom) and restructuring in digital and continuing education units.
The undergrad segment remains the anchor, accounting for 86% of revenue from medical school students, while continued education and medical practice solutions both posted healthy growth. B2B and B2P (business to physician) contracts in medical practice solutions surged, with B2B revenue up 28% and the active payer base up 11%. Cash flow conversion was strong at 109.7%, enabling Afya to maintain stable net debt despite significant M&A outlays.
- Undergrad Margin Leverage: Tuition hikes and seat maturation drove 170 bps gross margin gain in the segment.
- Medical Practice Solutions Acceleration: B2B contracts and payer growth highlight traction in digital monetization.
- Cash Generation Supports M&A: High operating cash flow offset acquisition outflows, keeping leverage in check.
Overall, Afya’s operational execution translated to above-inflation earnings growth, with margin expansion now a structural feature as the business scales and integrates acquisitions.
Executive Commentary
"Our number of undergrad medical students has reached more than 24,000 students, representing over 12% growth compared to the same period last year. Furthermore, our medical school net average ticket, excluding the UNI-DOM acquisition, increased almost 5% in the nine-month period."
Virgílio de Bom, Chief Executive Officer
"The expansion in the adjusted EBITDA margin is largely attributed to Gross margin expansions in the undergrad segments...and more efficiency in selling general and administrative expenses."
Luisa André Blanco, Chief Financial Officer
Strategic Positioning
1. M&A Discipline and Pipeline Expansion
Afya continues to execute a disciplined M&A strategy, targeting institutions highly concentrated in medicine and leveraging its capital allocation framework to secure lower acquisition multiples. The recent Unidom acquisition (300 new medical seats) was completed at a lower multiple, and management signals the pipeline is broadening as regulatory approvals increase the number of potential targets. Future deals are expected to be both accretive and less dilutive to margin.
2. Integrated Ecosystem and Cross-Segment Synergy
The company’s ecosystem now encompasses 326,000 physicians and medical students, with cross-segment synergies emerging as a key differentiator. Campus integration and unified product management have streamlined operations and reduced costs, while also enabling effective cross-selling between educational and digital offerings.
3. Operational Restructuring and Margin Expansion
Recent restructuring in continued education and digital units unified product management, eliminating redundant roles and consolidating delivery functions. This has already delivered margin gains in 2024, with further expansion expected from operational leverage as these segments scale.
4. Tuition Pricing and Enrollment Resilience
Afya’s ability to pass through above-inflation tuition increases while maintaining robust demand—evidenced by a higher candidate-to-seat ratio and enrollment rates up 10 percentage points year-over-year—demonstrates both pricing power and brand strength in a competitive market. The strategy of differentiated pricing by campus, combined with integrated student placement, further supports yield optimization.
5. Digital Platform Transition and Monetization
The migration from the legacy PEPMED portal to Portal Afya led to a temporary dip in monthly active users, but the transition is already showing improved payer conversion rates. The new platform is part of a broader digital brand strategy aimed at deepening engagement and monetization per user.
Key Considerations
Afya’s Q3 results underscore the benefits of scale, disciplined M&A, and operational restructuring, but also highlight areas for investor scrutiny as the company enters its next phase of growth.
Key Considerations:
- Acquisition Multiples Compression: Regulatory tailwinds are increasing the supply of potential M&A targets, allowing Afya to negotiate lower prices per seat and improve deal IRRs.
- Margin Expansion Drivers: Unification of product management and integration of acquired campuses are delivering cost efficiencies and setting up further operating leverage.
- Tuition and Enrollment Health: Resilient pricing and higher enrollment rates signal strong demand, but ongoing competitive dynamics warrant monitoring, especially as more seats enter the market.
- Cash Flow and Leverage Management: High cash conversion is offsetting M&A outflows, keeping net leverage stable and providing optionality for future growth investments or potential dividend initiation.
- Digital Monetization Trajectory: The Portal Afya transition is improving payer conversion, but sustained growth will depend on continued engagement and cross-sell execution.
Risks
Key risks include regulatory changes affecting seat approvals, pricing pressure from increased competition, and execution risk in integrating acquisitions and digital platform transitions. Mix shifts toward faster-growing, lower-margin segments could dampen consolidated margin expansion if not offset by operational leverage. Macroeconomic volatility and changes in student financing availability also remain external watchpoints.
Forward Outlook
For Q4 2024, Afya guided to:
- Continued margin expansion, driven by operational leverage and integration benefits.
- Stable to improving enrollment and tuition trends, with early indications of strong intake for the next academic cycle.
For full-year 2024, management maintained guidance:
- High-teens revenue growth and further margin expansion, supported by both organic and inorganic drivers.
Management highlighted several factors that will shape results:
- Ongoing M&A activity at lower multiples, with a focus on medicine-centric institutions.
- Operational leverage from restructuring and digital platform enhancements.
Takeaways
Afya’s Q3 demonstrated the compounding effects of scale, integration, and disciplined capital allocation. The company’s ability to expand margins while growing its core medical student base and digital revenues positions it well for further value creation, provided that execution on integration and digital monetization remains strong.
- Scale-Driven Margin Expansion: Integration and cost rationalization are structurally lifting margins, not just delivering one-off gains.
- M&A Optionality and Capital Discipline: Lower acquisition multiples and a robust pipeline provide levers for continued inorganic growth without overextending the balance sheet.
- Watch Digital and Enrollment Trends: Sustained payer growth on the new portal and resilience in tuition and intake will be critical to maintaining momentum into 2025.
Conclusion
Afya’s Q3 2024 results validate its integrated model and disciplined execution, with margin expansion and strong cash flow conversion underpinning both organic and inorganic growth. The company’s ability to navigate competitive and regulatory shifts while scaling its ecosystem will remain the key to its long-term value proposition.
Industry Read-Through
Afya’s results highlight the growing importance of scale, integration, and digital monetization in the Brazilian education and healthtech sectors. The ability to pass through tuition increases and maintain enrollment growth, even as regulatory seat expansion intensifies competition, signals that brand and operational excellence are key differentiators. For other education and healthcare digital platforms, the successful restructuring and unified product management model provide a roadmap for margin improvement. Sector peers should monitor acquisition multiples, digital engagement metrics, and the interplay between regulatory changes and pricing power as leading indicators of future performance.